News Briefs


Path to Purchase Institute webinar to address power of retail media

path to purchase webinar

Retail platforms are poised to be the new darling of the media industry — for good reason. However, retail media as a capability is still in its infancy, and not all retail media capabilities are created equal (or effective).

The Path to Purchase Institute will tackle this topic in an upcoming webinar, part of the Institute's Path to Purchase Now 2022 series, with a deep dive into retail media. Speakers Jonathan Lustig, head of revenue at Walgreens Advertising Group, and Andrea D'Emidio, director, omnichannel shopper marketing and e-commerce, at Johnson & Johnson, will discuss how open, integrated access to first-party data and closed-loop reporting create powerful, personalized campaigns and, ultimately, help marketers achieve their campaign goals up and down the funnel.

The webinar will take place on May 10 at 11 a.m. ET. Register now.


Voortman intros summer-inspired wafers

voortman wafers teaser

Voortman is debuting two new summer-inspired flavors of its well-known, fruit-flavored wafers.

Raspberry lemonade and tropical fruit varieties, which are seasonal flavors, contain the same light, crispy texture the brand has become synonymous with, as well as a creamy filling.

“With summer approaching, consumers are increasingly looking for snacks in sweet, refreshing flavors to enjoy on a warm day,” said Adam Lisook, general manager of Voortman Cookies. “Our raspberry lemonade and tropical fruit wafers contain real raspberries, lemons, pineapple and coconut, and are made without high fructose corn syrup, artificial colors or artificial flavors so consumers can feel good about eating them all season long.”

Available in a 10.6-oz. package, Voortman’s seasonal raspberry lemonade and tropical fruit wafers retail for $3.49 and can be found at retailers across the United States and Canada beginning in May.


Fortune partners with CVS Health to launch Fortune Well

health business teaser

Fortune magazine, in partnership with CVS Health, is launching a new health vertical titled Fortune Well.  

In announcing the new venture, Fortune CEO Alan Murray said that “the pandemic made it crystal clear to all of us that success in business is inextricably tied to health and well-being. You can’t have one without the other.”

Fortune editor-in-chief Alyson Shontell told her staff, “Our readers are juggling a lot. They have demanding jobs. Many are also raising children and helping aging parents, all while trying to stay healthy themselves. Many of you are navigating the same balancing act, so you know how tricky it can be .… When you are happy at home, you are more successful at work. It’s all connected.”

Murray said that the company has hired Jennifer Fields to serve as editor. Fields had roles at O Magazine, Weight Watchers, AOL Health, Good Housekeeping, WebMD and PopSugar. "She’s out recruiting a team to provide reliable and actionable advice on how to manage stress, stay fit, be more productive, develop better relationships, maintain brain health, enjoy active vacations and make better choices generally around well-being," he said. "We want our readers to enjoy good fortune in the broadest sense —and we know that’s not simply a matter of chance.”


Elixir Specialty to distribute Lenvima

Pill bottles with white pills

Elixir, a pharmacy benefit manager owned by Rite Aid, announced that its specialty pharmacy, Elixir Specialty, was recently selected to be added to the limited distribution network of only 13 pharmacies nationwide to distribute the cancer drug Lenvima (lenvatinib).

Due to the complexity of specialty medications, they are often released as limited distribution drugs to an exclusive network of pharmacies that can demonstrate the ability to provide the highest clinical standards, including an understanding of the disease state and the ability to properly handle and store the medication, as well as provide patient monitoring, education, support and care, which are needed to optimize the treatment.

Lenvima, a kinase inhibitor developed by Eisai, is an oral capsule indicated for the treatment of thyroid, kidney, liver and endometrial cancers, some in combination with other drugs. Like most oncology treatments, there is a risk of drug toxicity and adverse events.

“Our clinical program proactively addresses and mitigates risk to avoid premature therapeutic discontinuation,” said Jordan Maddocks, director of clinical services and outcomes at Elixir Specialty. “This allows members to continue with their treatment to get the most out of their therapy, improving their whole health.”


McKesson opens registration for in-person ideaShare 2022

A group of people walking in front of a crowd

McKesson ideaShare 2022 is returning as a live event from July 7 to 10 in Washington D.C.

By registering early, attendees may be eligible to earn a rebate of 2% of total OneStop Generics purchases of up to $4,000.

McKesson touts ideaShare as the nation’s premier community pharmacy event that empowers current and future independent pharmacists to foster deeper connections, discover ways to innovate and thrive, and strengthen their collective voice. Featuring a range of large group sessions and smaller roundtable discussions to an energetic show floor, the meeting has been reimagined to give independent pharmacists and their staff a customized experience focused on building a brighter future for the independent pharmacy industry — together.

 Attendees will learn how to:

  • Run their business better;
  • Provide quality care;
  • Maximize profitability;
  • Diversify their services; and
  • Strengthen the industry’s voice.

 Registration is open here.


Lightlife launches plant-based chicken options

lightlife plant-based chicken

Lightlife is continuing to expand upon its plant-based food options by debuting two new takes on traditional chicken.

Its plant-based chicken breasts and plant-based chicken strips are made with simple ingredients that mimic the texture and flavor of chicken, the Chicago-based company said.

“Lightlife Plant-Based Chicken Breasts and Strips deliver a chicken-like eating experience and versatility that is unmatched," said Jitendra Sagili, chief research and development and food technology officer of Greenleaf Foods, SPC. "These products reflect our vision of relentlessly evolving the product designs, utilizing ingredient technologies delivering on consumers’ expectations for taste, color and texture.”

The plant-based chicken breasts and chicken strips offer between 9 to 6 g of protein per serving, and are made using the brand’s high-moisture extrusion technology to deliver a juice texture similar to the traditional chicken experience.

Made with pea protein, both plant-based chicken offerings are Non-GMO Project Verified, vegan certified and do not contain artificial flavors.

“Plant-based chicken is the No. 2 selling plant-based protein segment based on dollar sales, with a category size of $308 million, creating a significant opportunity to drive the segment forward and bring in new consumers,” said Adam Grogan, president of Greenleaf Foods, SPC. “We’re excited to invite consumers to experiment with Lightlife plant-based chicken breasts and strips across a variety of hot and cold applications.”

Consumers can find Lightlife’s plant-based chicken breasts and chicken strips at Publix and Whole Foods Market locations nationwide.